Back

Pharmapulse report—does the arrival of factor XI inhibitors mark the end of the NOAC era?

European Heart Journal - Cardiovascular Pharmacotherapy

28 January 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Koji Hasegawa
Koji Hasegawa

Author

National Hospital Organization Kyoto Medical Centre Kyoto , Japan

Takanori Ikeda
Takanori Ikeda

Author

You may be interested in
thumbnail
Congress Session
The new frontier in oral anticoagulation: Factor XIa inhibitors
16 April 2023
thumbnail
Congress Presentation
31 August 2019
thumbnail
Congress Presentation
Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71
1 September 2025
thumbnail
Congress Presentation
Early DOAC therapy after invasive acute pulmonary embolism therapy: fast track PE?
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources